TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up (TRUST)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00336284 |
Recruitment Status :
Completed
First Posted : June 13, 2006
Results First Posted : March 30, 2010
Last Update Posted : August 3, 2010
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Patient Indicated for an ICD | Other: Home Monitoring Other: In-Office Conventional Follow-up | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 1450 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up |
Study Start Date : | November 2005 |
Actual Primary Completion Date : | June 2009 |
Actual Study Completion Date : | June 2009 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Home Monitoring
Home Monitoring programmed on.
|
Other: Home Monitoring
Home Monitoring programmed on. In-office and Home Monitoring evaluation at 3 and 15 months post ICD implant. Home Monitoring evaluation only at 6, 9, and 12 months post ICD implant. |
In-Office Conventional Follow-up
Home Monitoring programmed off.
|
Other: In-Office Conventional Follow-up
Home Monitoring programmed off. In-office evaluations at 3, 6, 9, 12, and 15 months post ICD implant. |
- Home Monitoring Effectiveness [ Time Frame: 12 months ]Average number of office-based implantable cardioverter defibrillator (ICD) follow-up visits in the Home Monitoring arm vs the Conventional (calendar-based) follow-up arm.
- Percent of Participants Experiencing Death, Incidence of Stroke, or Event Requiring Surgical Intervention. [ Time Frame: 12 months ]Percentage of participants experiencing death, incidence of stroke, or event(s) requiring surgical intervention. Outcome measure time frame is 12 months.
- Early Detection of Cardiac Events [ Time Frame: 12 months ]Detection time relative to onset of cardiac events (atrial fibrillation, ventricular tachycardia, ventricular fibrillation).
- Patient Initiated Follow-up [ Time Frame: 12 months ]Percentage of total patient initiated inqueries that result in ER or office follow-up visits.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Implanted within the last 45 days or being considered for implant with a BIOTRONIK ICD with Home Monitoring (HM)/Intracardiac Electrogram (IEGM)-Online technology, or legally marketed future generation device with HM/IEGM Online.
- Able to utilize the HM system throughout the study
- Ability to give informed consent
- Geographically stable and able to return for regular follow-ups for fifteen (15) months
- At least 18 years old
Exclusion Criteria:
- Patients who do not fulfill all inclusion criteria
- Pacemaker dependent
- Currently enrolled in any other cardiac clinical investigation

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00336284

Principal Investigator: | Niraj Varma, MD, FRCP | The Cleveland Clinic |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Justin Michalski, M.S. / Clinical Studies Engineer, BIOTRONIK, Inc. |
ClinicalTrials.gov Identifier: | NCT00336284 |
Other Study ID Numbers: |
20052069 |
First Posted: | June 13, 2006 Key Record Dates |
Results First Posted: | March 30, 2010 |
Last Update Posted: | August 3, 2010 |
Last Verified: | July 2010 |
Telemonitoring ICD Reduction of office follow-ups |